Exact Mass: 248.0868666
Exact Mass Matches: 248.0868666
Found 500 metabolites which its exact mass value is equals to given mass value 248.0868666,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Sudan_I
C16H12N2O (248.09495819999998)
C.i. solvent yellow 14 appears as dark reddish-yellow leaflets or orange powder. Slight odor. (NTP, 1992) Sudan I is a monoazo compound. It has a role as a dye. It is functionally related to a 2-naphthol. D009676 - Noxae > D002273 - Carcinogens D004396 - Coloring Agents CONFIDENCE standard compound; INTERNAL_ID 5651
Pyrimethamine
Pyrimethamine is only found in individuals that have used or taken this drug. It is one of the folic acid antagonists that is used as an antimalarial or with a sulfonamide to treat toxoplasmosis. [PubChem]Pyrimethamine inhibits the dihydrofolate reductase of plasmodia and thereby blocks the biosynthesis of purines and pyrimidines, which are essential for DNA synthesis and cell multiplication. This leads to failure of nuclear division at the time of schizont formation in erythrocytes and liver. CONFIDENCE standard compound; INTERNAL_ID 1363; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7091; ORIGINAL_PRECURSOR_SCAN_NO 7088 CONFIDENCE standard compound; INTERNAL_ID 1363; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7117; ORIGINAL_PRECURSOR_SCAN_NO 7114 CONFIDENCE standard compound; INTERNAL_ID 1363; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7128; ORIGINAL_PRECURSOR_SCAN_NO 7126 CONFIDENCE standard compound; INTERNAL_ID 1363; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7117; ORIGINAL_PRECURSOR_SCAN_NO 7115 CONFIDENCE standard compound; INTERNAL_ID 1363; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7093; ORIGINAL_PRECURSOR_SCAN_NO 7091 P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BD - Diaminopyrimidines D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists
5-Hydroxyindoleacetylglycine
C12H12N2O4 (248.07970319999998)
5-Hydroxyindoleacetylglycine is found in Tryptophan metabolism [Kegg: C05832] [HMDB] 5-Hydroxyindoleacetylglycine is found in Tryptophan metabolism [Kegg: C05832].
Pyriculol
A benzaldehyde that is salicylaldehyde which is substituted at position 6 by a (3R,4S,5E)-3,4-dihydroxyhepta-1,5-dien-1-yl group. It is a phytotoxic metabolite, isolated from the rice blast fungi Magnaporthe oryzae and Magnaporthe grisea.
1-Hydroxy-6-methoxypyrene
This compound belongs to the family of Pyrenes. These are compounds containing a pyrene moiety, which consists four fused benzene rings, resulting in a flat aromatic system.
Mycorradicin
Mycorradicin is a member of the class of compounds known as medium-chain fatty acids. Medium-chain fatty acids are fatty acids with an aliphatic tail that contains between 4 and 12 carbon atoms. Mycorradicin is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Mycorradicin can be found in corn, which makes mycorradicin a potential biomarker for the consumption of this food product.
(+)-cis-5,6-Dihydro-5-hydroxy-4-methoxy-6-(2-phenylethyl)-2H-pyran-2-one
(+)-cis-5,6-Dihydro-5-hydroxy-4-methoxy-6-(2-phenylethyl)-2H-pyran-2-one is found in beverages. (+)-cis-5,6-Dihydro-5-hydroxy-4-methoxy-6-(2-phenylethyl)-2H-pyran-2-one is found in kava (Piper methysticum). FDA advises against use of kava in food due to potential risk of severe liver damage (2002
Glutamylthreonine
C9H16N2O6 (248.10083160000002)
Glutamylthreonine is a dipeptide composed of glutamate and threonine, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Glutamylthreonine is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Gamma-Glutamylthreonine
C9H16N2O6 (248.10083160000002)
gamma-Glutamylthreonine is a dipeptide composed of gamma-glutamate and threonine, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. gamma-Glutamylthreonine is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Prenyl cis-caffeate
Prenyl cis-caffeate is a constituent of Populus species Prenyl cis-caffeate is a flavouring agent. Constituent of Populus subspecies
Citreovirenone
Citreovirenone is a mycotoxin produced by the rice storage mould Penicillium citreo-viride B. Mycotoxin production by the rice storage mould Penicillium citreo-viride B.
3-{4-hydroxy-3-[(2E)-4-hydroxy-3-methylbut-2-en-1-yl]phenyl}prop-2-enoic acid
3-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]prop-2-enoic acid
3-[2,4-Dihydroxy-5-(3-methylbut-2-en-1-yl)phenyl]prop-2-enoic acid
3-[2,4-dihydroxy-3-(3-methyl-2-butenyl)phenyl]-2-propenoic acid
Threonylglutamic acid
C9H16N2O6 (248.10083160000002)
Threonylglutamic acid is a dipeptide composed of threonine and glutamic acid. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
7-Hydroxy-6-(methoxyacetyl)-2,2-dimethyl-2H-1-benzopyran
7-Hydroxy-6-(methoxyacetyl)-2,2-dimethyl-2H-1-benzopyran is found in fats and oils. 7-Hydroxy-6-(methoxyacetyl)-2,2-dimethyl-2H-1-benzopyran is a constituent of Madia sativa (Chile tarweed)
p-Hydroxyphenobarbital
C12H12N2O4 (248.07970319999998)
p-Hydroxyphenobarbital is a metabolite of Phenobarbital. Phenobarbital (INN) is a barbiturate and the most widely used anticonvulsant worldwide, and the oldest still commonly used. It also has sedative and hypnotic properties. (Wikipedia)
Hydroxynalidixic acid
C12H12N2O4 (248.07970319999998)
Hydroxynalidixic acid is a metabolite of nalidixic acid. Nalidixic acid (tradenames Nevigramon, Neggram, Wintomylon and WIN 18,320) is the first of the synthetic quinolone antibiotics. In the technical sense, it is a naphthyridone, not a quinolone: its ring structure is a 1,8-naphthyridine nucleus that contains two nitrogen atoms, unlike quinoline, which has a single nitrogen atom. (Wikipedia)
6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide
C26170 - Protective Agent > C1509 - Neuroprotective Agent Selisistat (EX-527) is a potent and selective SirT1 (Sir2 in Drosophila melanogaster) inhibitor with an IC50 of 123 nM for SirT1. Selisistat alleviates pathology in multiple animal and cell models of Huntington's disease[1][2].
3-(3-(Pyridin-3-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
NS9283 is a positive positive allosteric modulator of (α4)3(β2)2 nicotinic ACh receptors. NS9283 can be used in a series of neurological conditions such as attention deficit hyperactivity disorder (ADHD), schizophrenia, Parkinson's disease and Alzheimer's disease[1].
Tetrahydrouridine
C9H16N2O6 (248.10083160000002)
2-(5'-methylthio)pentylmalate
2-(5-methylthio)pentylmalate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 2-(5-methylthio)pentylmalate can be found in a number of food items such as colorado pinyon, yellow bell pepper, asian pear, and celery stalks, which makes 2-(5-methylthio)pentylmalate a potential biomarker for the consumption of these food products.
3-(5'-methylthio)pentylmalate
3-(5-methylthio)pentylmalate is slightly soluble (in water) and a weakly acidic compound (based on its pKa). 3-(5-methylthio)pentylmalate can be found in a number of food items such as evening primrose, other bread, sunflower, and broad bean, which makes 3-(5-methylthio)pentylmalate a potential biomarker for the consumption of these food products.
HARMINE HCl
Harmine Hydrochloride (Telepathine Hydrochloride) is a natural DYRK inhibitor with anticancer and anti-inflammatory activities. Harmine has a high affinity of 5-HT2A serotonin receptor, with an Ki of 397 nM[1]. Harmine Hydrochloride (Telepathine Hydrochloride) is a natural DYRK inhibitor with anticancer and anti-inflammatory activities. Harmine has a high affinity of 5-HT2A serotonin receptor, with an Ki of 397 nM[1]. Harmine Hydrochloride (Telepathine Hydrochloride) is a natural DYRK inhibitor with anticancer and anti-inflammatory activities. Harmine has a high affinity of 5-HT2A serotonin receptor, with an Ki of 397 nM[1].
Harmine
Harmine Hydrochloride (Telepathine Hydrochloride) is a natural DYRK inhibitor with anticancer and anti-inflammatory activities. Harmine has a high affinity of 5-HT2A serotonin receptor, with an Ki of 397 nM[1]. Harmine Hydrochloride (Telepathine Hydrochloride) is a natural DYRK inhibitor with anticancer and anti-inflammatory activities. Harmine has a high affinity of 5-HT2A serotonin receptor, with an Ki of 397 nM[1]. Harmine Hydrochloride (Telepathine Hydrochloride) is a natural DYRK inhibitor with anticancer and anti-inflammatory activities. Harmine has a high affinity of 5-HT2A serotonin receptor, with an Ki of 397 nM[1].
Pyriculariol
A member of the class of benzaldehydes that is salicylaldehyde which is substituted at position 6 by a (1E,3E,5R,6S)-5,6-dihydroxyhepta-1,3-dien-1-yl group. An isomer of pyriculol.
2-Hydroxy-1-(7-methoxy-2,2-dimethyl-2H-1-benzopyran-6-yl)-ethanone
7-Hydroxy-4-(3-methylbutoxy)-2H-1-benzopyran-2-one
3beta-methoxy-2, 3-dihydrobenzofuran|6-acetyl-5-hydroxy-2-isopropenyl-3-methoxy-2,3-dihydrobenzofuran|6-acetyl-5-hydroxy-2-isopropenyl-3beta-methoxy-2,3-dihydrobenzofuran
(3R,3aR)-3-(3-furanyl)-3a-methyl-7-hydroxymethyl-6-hydroxy-1,3,3a,4,5,6-hexahydrobenzo[c]furan-1-one|10-hydroxyfraxinellone|30-hydroxyfraxinellone
(6S)-4-(2,4-hexadienoyl)-3,6-dihydroxy-2,6-dimethyl-2,4-cyclohexadien-1-one|sorbicillinol
8-Methyl-8-(hydroxymethyl)-3,4-dihydro-2H,8H-benzo[1,2-b:3,4-b]dipyran-3-ol
2,2,5-Trimethyl-7-hydroxy-2H-1-benzopyran-6-carboxylic acid methyl ester
(E)-4-hydroxy-2-methoxy-5-(1-oxo-4-hexenyl)-benzaldehyde
2,2-Dimethyl-8-methoxy-2H-1-benzopyran-6-carboxylic acid methyl ester
4-(1-hydroxy-2-butenyl)-1,4-dihydro-2,3-benzodioxocin-10-ol
6-Ethyl-4H-indolo[3,2,1-de][1,5]naphthyridine-4-one
C16H12N2O (248.09495819999998)
Trans-dec-8.en-4,6-diyn-1-yl-cis-3-methylthioacrylat
(3S*,4S*,5R*)-(E)-3,4-dihydroxy-2-(hexa-2,4-diyniliden)-1,6-dioxaspiro-(4.5)-decane|(3S*,4S*,5R*)-(E)-3,4-Dihydroxy-2-(hexa-2,4-diynyliden)-1,6-dioxaspiro-(4,5)decane|(E)-3beta,4alpha-dihydroxyl-2-(2,4-hexadiynylidene)-1,6-dioxaspiro[4,5]decane
3-(5-methylene-2-oxo-6-penta-1,3-dienyl-5,6-dihydro-2H-pyran-3-yl)propionic acid|Dykellic acid
1-(2-methoxy-3-formyl-but-3-en-1-yl)-resacetophenone|1-<2-methoxy-3-formyl-but-3-en-1-yl>-resacetophenone
2,2,7-Trimethyl-5-hydroxy-2H-1-benzopyran-6-carboxylic acid methyl ester
nigerapyrone D
A member of the class of 2-pyranones that is 2H-pyran-2-one substituted by a methoxy group at position 4, a methyl group at position 3 and a 3-methyl-5-oxohexa-1,3-dien-1-yl group at position 6. It has been isolated from an endophytic fungus Aspergillus niger.
3-[(2E)-but-2-en-1-yl]-5-hydroxy-5,7-dimethyl-4,5-dihydro-1-benzofuran-2,6-dione|phialofurone
(4aR,8S,8aR,9aS)-8-hydroxy-3,8a-dimethyl-4,4a,8,8a,9,9a-hexahydronaphtho[2,3-b]furan-2,5-dione|linderolide H
2,6-Dimethyl-4-amino-7-methoxy-3,5,8(2H)-isoquinolinetrione
C12H12N2O4 (248.07970319999998)
3-ethoxycarbonyl-3-hydroxyglutaric acid 1,5-dimethyl ester
7-Hydroxy-2-(2-hydroxybutyl)-5-methyl-2-chromene-4-one
4-acetyl-3-hydroxy-1-hydroxymethyl-6-methyl-5-oxo-5,6,7,8-tetrahydronaphthalene|goldfussin B
1,3-Dimethyl-6-propionylpteridine-2,4(1H,3H)-dione
(E)-3-(2,2-dimethyl-3,4-dihydro-3-hydroxy-2H-1-benzopyran-6-yl)-2-propenoic acid
Selisistat
C26170 - Protective Agent > C1509 - Neuroprotective Agent Selisistat (EX-527) is a potent and selective SirT1 (Sir2 in Drosophila melanogaster) inhibitor with an IC50 of 123 nM for SirT1. Selisistat alleviates pathology in multiple animal and cell models of Huntington's disease[1][2].
Thiamet G
(1Z,2E,4E)-5-(2,4-Hexadienylidene)-5,6-dihydro-2-oxo-2H-pyran-3-propanoic acid
HARMINE HCl
Harmine Hydrochloride (Telepathine Hydrochloride) is a natural DYRK inhibitor with anticancer and anti-inflammatory activities. Harmine has a high affinity of 5-HT2A serotonin receptor, with an Ki of 397 nM[1]. Harmine Hydrochloride (Telepathine Hydrochloride) is a natural DYRK inhibitor with anticancer and anti-inflammatory activities. Harmine has a high affinity of 5-HT2A serotonin receptor, with an Ki of 397 nM[1]. Harmine Hydrochloride (Telepathine Hydrochloride) is a natural DYRK inhibitor with anticancer and anti-inflammatory activities. Harmine has a high affinity of 5-HT2A serotonin receptor, with an Ki of 397 nM[1].
pyrimethamine
P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01B - Antimalarials > P01BD - Diaminopyrimidines D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists [Raw Data] CB119_Pyrimethamine_pos_50eV_CB000043.txt [Raw Data] CB119_Pyrimethamine_pos_40eV_CB000043.txt [Raw Data] CB119_Pyrimethamine_pos_30eV_CB000043.txt [Raw Data] CB119_Pyrimethamine_pos_20eV_CB000043.txt [Raw Data] CB119_Pyrimethamine_pos_10eV_CB000043.txt
gamma-Glutamylthreonine
C9H16N2O6 (248.10083160000002)
A dipeptide composed of glutamic acid and threonine joined by a peptide linkage.
(2S,3R)-3-hydroxy-4-methoxy-2-(2-phenylethyl)-2,3-dihydropyran-6-one
8-hydroxy-3-(4-oxopentyl)-3,4-dihydroisochromen-1-one
C14H16O4_2H-Pyran-2-one, 5,6-dihydro-5-hydroxy-4-methoxy-6-(2-phenylethyl)-, (5S,6S)
Glu-THR
C9H16N2O6 (248.10083160000002)
A dipeptide composed of L-glutamic acid and L-threonine joined by a peptide linkage.
(2S,3S)-3-hydroxy-4-methoxy-2-(2-phenylethyl)-2,3-dihydropyran-6-one
(2S,3R)-3-hydroxy-4-methoxy-2-(2-phenylethyl)-2,3-dihydropyran-6-one
(2S,3R)-3-hydroxy-4-methoxy-2-(2-phenylethyl)-2,3-dihydropyran-6-one [IIN-based on: CCMSLIB00000846131]
8-hydroxy-3-(4-oxopentyl)-3,4-dihydroisochromen-1-one [IIN-based on: CCMSLIB00000847794]
8-hydroxy-3-(4-oxopentyl)-3,4-dihydroisochromen-1-one [IIN-based: Match]
(2S,3R)-3-hydroxy-4-methoxy-2-(2-phenylethyl)-2,3-dihydropyran-6-one [IIN-based: Match]
Sudan I
C16H12N2O (248.09495819999998)
CONFIDENCE standard compound; INTERNAL_ID 297; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10862; ORIGINAL_PRECURSOR_SCAN_NO 10860 D009676 - Noxae > D002273 - Carcinogens D004396 - Coloring Agents CONFIDENCE standard compound; INTERNAL_ID 297; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10878; ORIGINAL_PRECURSOR_SCAN_NO 10876 CONFIDENCE standard compound; INTERNAL_ID 297; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10910; ORIGINAL_PRECURSOR_SCAN_NO 10908 CONFIDENCE standard compound; INTERNAL_ID 297; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10917; ORIGINAL_PRECURSOR_SCAN_NO 10916 CONFIDENCE standard compound; INTERNAL_ID 297; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10908; ORIGINAL_PRECURSOR_SCAN_NO 10905 CONFIDENCE standard compound; INTERNAL_ID 297; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10943; ORIGINAL_PRECURSOR_SCAN_NO 10942
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(2-hydroxyethyl)-5-phenyl-
C12H12N2O4 (248.07970319999998)
p-Hydroxyphenobarbital
C12H12N2O4 (248.07970319999998)
EX-527
Selisistat (EX-527) is a potent and selective SirT1 (Sir2 in Drosophila melanogaster) inhibitor with an IC50 of 123 nM for SirT1. Selisistat alleviates pathology in multiple animal and cell models of Huntington's disease[1][2].
5-hydroxy-4-methoxy-6-(2-phenylethyl)-5,6-dihydro-2H-pyran-2-one
7-Hydroxy-6-(methoxyacetyl)-2,2-dimethyl-2H-1-benzopyran
Coriandrone E
2-(3-OXO-PIPERAZINE-1-CARBONYL)-BENZOIC ACID
C12H12N2O4 (248.07970319999998)
2-piperidin-3-ylaniline,dihydrochloride
C11H18Cl2N2 (248.08469680000002)
5-(2,5-dimethoxyphenyl)-1h-pyrazole-3-carboxylic acid
C12H12N2O4 (248.07970319999998)
(4-METHYL-1,3-THIAZOL-2-YL)ACETONITRILE
C12H12N2O4 (248.07970319999998)
1,1-(1,4-Butanediyl)bis(1H-pyrrole-2,5-dione)
C12H12N2O4 (248.07970319999998)
2-(3,4-DIMETHYLBENZOYL)-3-OXO-BUTYRICACIDMETHYLESTER
Dimethyl 5-methyl-1H-pyrrolo[2,3-b]pyridine-1,3-dicarboxylate
C12H12N2O4 (248.07970319999998)
2-Methyl-2-propanyl 3-(4-methylphenyl)-2,3-dioxopropanoate
5-(2,4-dimethoxyphenyl)-1H-pyrimidine-2,4-dione
C12H12N2O4 (248.07970319999998)
6-(1,1-DIMETHYLPROPYL)-1-BENZOTHIOPHENE-3-CARBOXYLIC ACID
Ethyl 5-(4-methoxyphenyl)-1,3,4-oxadiazole-2-carboxylate
C12H12N2O4 (248.07970319999998)
Ethyl 4-methyl-7-nitro-1H-indole-2-carboxylate
C12H12N2O4 (248.07970319999998)
1-Benzylpiperazine dihydrochloride
C11H18Cl2N2 (248.08469680000002)
1-(4-Nitrobenzoyl)tetrahydro-4(1H)-pyridinone
C12H12N2O4 (248.07970319999998)
(4-ISOPROPOXY-2-(TRIFLUOROMETHYL)PHENYL)BORONIC ACID
C10H12BF3O3 (248.08315480000002)
ethyl 5-hydroxy-2-oxo-1,3-dihydropyrido[4,3-b]azepine-4-carboxylate
C12H12N2O4 (248.07970319999998)
3-(2-amino-2-carboxyethyl)-1H-indole-4-carboxylic acid
C12H12N2O4 (248.07970319999998)
(1R)-1-(2,3-dihydro-1H-indol-7-yl)propan-1-amine,dihydrochloride
C11H18Cl2N2 (248.08469680000002)
(1S)-1-(2,3-dihydro-1H-indol-7-yl)propan-1-amine,dihydrochloride
C11H18Cl2N2 (248.08469680000002)
1-(3-Methylphenyl)piperazine dihydrochloride
C11H18Cl2N2 (248.08469680000002)
3-(3,4-DIETHOXY-PHENYL)-PROPYLAMINE
C13H16N2OS (248.09832859999997)
ethyl 1-methyl-5-nitroindole-2-carboxylate
C12H12N2O4 (248.07970319999998)
3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]propanoic acid
C12H12N2O4 (248.07970319999998)
7H-Pyrido(4,3-c)carbazole, 10-methoxy-
C16H12N2O (248.09495819999998)
EX-527 (S-enantiomer)
(S)-Selisistat ((S)-EX-527) is a potent and selective SIRT1 inhibitor, with an IC50 of 98 nM.
Propanebis(thioic)acid,S1,S3-bis(1,1-dimethylethyl) ester
C11H20O2S2 (248.09046600000002)
(2-ISOPROPOXY-5-(TRIFLUOROMETHYL)PHENYL)BORONIC ACID
C10H12BF3O3 (248.08315480000002)
4-(TERT-BUTOXY)-2,3,5,6-TETRAFLUOROSTYRENE
C12H12F4O (248.08242299999998)
2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexene-1-carboxaldehyde
5,6-DIAMINO-1-ETHYL-3-PROPYLPYRIMIDINE-2,4(1H,3H)-DIONE HYDROCHLORIDE
4-(3-Piperidyl)aniline Dihydrochloride
C11H18Cl2N2 (248.08469680000002)
ETHYL 8-METHOXY-4-OXO-1,4-DIHYDRO-1,5-NAPHTHYRIDINE-3-CARBOXYLATE
C12H12N2O4 (248.07970319999998)
Propanedioic acid, 2-[(2E)-3-chloro-2-propen-1-yl]-2-(1-methylethyl)-, 1,3-dimethyl ester
1-(2-methylphenyl)piperazine,dihydrochloride
C11H18Cl2N2 (248.08469680000002)
4-CHLOROCARBONYL-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
2-(4-chlorophenyl)-1,3-diazaspiro[4.4]non-1-en-4-one
1,5-DIPHENYL-1H-PYRAZOLE-3-CARBALDEHYDE
C16H12N2O (248.09495819999998)
Tetrahydrouridine
C9H16N2O6 (248.10083160000002)
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2135 - Cytidine Deaminase Inhibitor D009676 - Noxae > D000963 - Antimetabolites
3-[3-(2-methoxyphenyl)-1,2,4-oxadiazol-5-yl]propanoic acid
C12H12N2O4 (248.07970319999998)
4-(1-pyrrolidinylmethyl)-benzenamine dihydrochloride
C11H18Cl2N2 (248.08469680000002)
1-(4-FLUOROPHENYL)-3-METHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID ETHYL ESTER
3-(3-(PYRIDIN-2-YL)-1,2,4-OXADIAZOL-5-YL)BENZONITRILE
(2-PROPOXY-5-(TRIFLUOROMETHYL)PHENYL)BORONIC ACID
C10H12BF3O3 (248.08315480000002)
(4-PROPOXY-2-(TRIFLUOROMETHYL)PHENYL)BORONIC ACID
C10H12BF3O3 (248.08315480000002)
(3-ISOPROPOXY-5-(TRIFLUOROMETHYL)PHENYL)BORONIC ACID
C10H12BF3O3 (248.08315480000002)
(3-PROPOXY-5-(TRIFLUOROMETHYL)PHENYL)BORONIC ACID
C10H12BF3O3 (248.08315480000002)
6-Methylpyridinyl-2-boronic acid MIDA ester
C11H13BN2O4 (248.09683280000002)
2-ACETYL-8-CHLORO-2,3,4,5-TETRAHYDRO-1H-PYRIDO[4,3-B]INDOLE
1,3-diphenylpyrazole-4-carbaldehyde
C16H12N2O (248.09495819999998)
ETHYL 4-HYDROXY-7-METHYL-2-OXO-1,2-DIHYDRO-1,8-NAPHTHYRIDINE-3-CARBOXYLATE
C12H12N2O4 (248.07970319999998)
3-(6-(Methoxycarbonyl)naphthalen-2-yl)benzoic acid
1-ethyl-3-methylimidazol-3-ium,trifluoro(trifluoromethyl)boranuide
C7H11BF6N2 (248.09194279999997)
5-(Benzyloxy)-1H-indole-3-carbonitrile
C16H12N2O (248.09495819999998)
6-CHLORO-N4-(1-PHENYL-ETHYL)-PYRIMIDINE-4,5-DIAMINE
3-(2,5-DIMETHOXYPHENYL)-1H-PYRAZOLE-5-CARBOXYLIC ACID
C12H12N2O4 (248.07970319999998)
ETHYL 4-HYDROXY-1-METHYL-2-OXO-1,2-DIHYDRO-1,8-NAPHTHYRIDINE-3-CARBOXYLATE
C12H12N2O4 (248.07970319999998)
Methyl 5,6-dimethoxy-3,4-dihydro-1-naphthalenecarboxylate
(3-Trifluoromethyl-4,5,6,7-tetrahydro-indazol-1-yl)-acetic acid
Piperazine,1-(4-methylphenyl)-, hydrochloride (1:2)
C11H18Cl2N2 (248.08469680000002)
CYCLOPENTYLMETHYL-PYRIDIN-4-YL-AMINE DIHYDROCHLORIDE
C11H18Cl2N2 (248.08469680000002)
3-acetamido-5-methoxy-1H-indole-2-carboxylate
C12H12N2O4 (248.07970319999998)
3-(2,5-dioxo-4-phenyl-imidazolidin-4-yl)propanoic acid
C12H12N2O4 (248.07970319999998)
1H-1,2,4-Triazole-3-carboxamide,N-(3,4-dimethoxyphenyl)-(9CI)
Ethyl 6-acetoxy-1H-pyrrolo[2,3-b]pyridine-2-carboxylate
C12H12N2O4 (248.07970319999998)
Topiroxostat
C471 - Enzyme Inhibitor > C1637 - Xanthine Oxidase Inhibitor D004791 - Enzyme Inhibitors
N-phenylpiperidin-4-amine,dihydrochloride
C11H18Cl2N2 (248.08469680000002)
1-Phenyl-4-piperidinamine dihydrochloride
C11H18Cl2N2 (248.08469680000002)
4-piperidin-4-ylmethylpyridine dihydrochloride
C11H18Cl2N2 (248.08469680000002)
[4-(1-Naphthyl)phenyl]boronic acid
C16H13BO2 (248.10085480000004)
(S)-3-amino-1-benzylpyrrolidine dihydrochloride
C11H18Cl2N2 (248.08469680000002)
1-(4-Methoxy-phenyl)-5-Methyl-2-oxo-2,3-dihydro-1H-imidazole-4-carboxylic acid
C12H12N2O4 (248.07970319999998)
(r)-3-amino-1-benzylpyrrolidine dihydrochloride
C11H18Cl2N2 (248.08469680000002)
4-chloro-6-(methoxymethyl)-2-(3-methylphenyl)pyrimidine
5-DIMETHYLAMINO-2-(2-THIAZOLYLAZO)PHENOL
C11H12N4OS (248.07317819999997)
(3-Butoxy-2,4,6-trifluorophenyl)boronic acid
C10H12BF3O3 (248.08315480000002)
6-amino-4-phenyl-2-sulfanylidene-3,4-dihydro-1H-pyrimidine-5-carboxamide
C11H12N4OS (248.07317819999997)
4-(2,6-Dimethylphenoxy)phthalonitrile
C16H12N2O (248.09495819999998)
6-Benzothiazolamine,2-propyl-(9CI)
C12H12N2O4 (248.07970319999998)
3-(2,5-DIOXO-4-PHENYL-IMIDAZOLIDIN-4-YL)PROPIONIC ACID
C12H12N2O4 (248.07970319999998)
1,2,5,6-TETRAHYDRO-6-(2-HYDROXYPHENYL)-4-METHYL-2-OXO-5-PYRIMIDINECARBOXYLIC ACID
C12H12N2O4 (248.07970319999998)
methyl 4-(4-fluorophenyl)-2,5-dimethylfuran-3-carboxylate
2-(3-Methoxybenzylidene)-3-oxobutyric acid ethyl ester
(S)-BENZYL 2,6-DIOXOHEXAHYDROPYRIMIDINE-4-CARBOXYLATE
C12H12N2O4 (248.07970319999998)
Triethyloxonium hexafluorophosphate(1-)
C6H15F6OP (248.07646619999997)
a-D-Xylofuranose,1,2-O-(1-methylethylidene)-, 5-(methyl carbonate) (9CI)
(Z)-7-[(1R,2R,3R,5S)-5-ACETOXY-2-FORMYL-3-(TETRAHYDRO-PYRAN-2-YLOXY)-CYCLOPENTYL]-HEPT-5-ENOICACIDMETHYLESTER
C12H12N2O4 (248.07970319999998)
(9-OXO-4,5,6,7,8,9-HEXAHYDRO-[1,2,4]TRIAZOLO-[5,1-B]QUINAZOLIN-2-YL)-ACETIC ACID
4-(NAPHTHALEN-1-YL)PHENYLBORONIC ACID
C16H13BO2 (248.10085480000004)
1-(2-Methoxyphenyl)-4-oxocyclohexanecarboxylic acid
1-(3-Methoxyphenyl)-4-oxocyclohexanecarboxylic acid
2-Benzylpiperazine dihydrochloride
C11H18Cl2N2 (248.08469680000002)
[3-(1-Naphthyl)phenyl]boronic acid
C16H13BO2 (248.10085480000004)
beta-[3-(2-Naphthalenyl)phenyl]boronic acid
C16H13BO2 (248.10085480000004)
[2-(2-Naphthyl)phenyl]boronic acid
C16H13BO2 (248.10085480000004)
ethyl 5-(4-methoxyphenyl)-1,2,4-oxadiazole-3-carboxylate
C12H12N2O4 (248.07970319999998)
1,2,3,4-TETRAHYDRO-4-(P-HYDROXYPHENYL)-6-METHYL-2-OXO-5-PYRIMIDINECARBOXYLIC ACID
C12H12N2O4 (248.07970319999998)
ethyl 3-[4-(1,3-dioxolan-2-yl)phenyl]prop-2-enoate
Censavudine
C12H12N2O4 (248.07970319999998)
C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent
N-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]guanidine
C11H12N4OS (248.07317819999997)
(R)-6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide
(R)-Selisistat ((R)-EX-527) is a R-enantiomer of Selisistat. Selisistat (EX-527) is a potent and selective SIRT1 inhibitor with IC50 of 98 nM.
5-[(E)-(5-aminotetrazol-1-yl)iminomethyl]-2-ethoxyphenol
C10H12N6O2 (248.10216920000002)
4-[2-(2,4-Dioxopentan-3-ylidene)hydrazinyl]benzoic acid
C12H12N2O4 (248.07970319999998)
2-(1-Methoxy-2-(naphthalen-1-yl)ethylidene)malononitrile
C16H12N2O (248.09495819999998)
2,2-dimethyl-N-(6-methyl-1,3-benzothiazol-2-yl)propanamide
C13H16N2OS (248.09832859999997)
(5S,6S)-4-Methoxy-5-hydroxy-6-phenethyl-5,6-dihydro-2H-pyran-2-one
4H-Pyrido[1,2-a]pyrimidine-3-acetic acid, 9-hydroxy-4-oxo-, ethyl ester
C12H12N2O4 (248.07970319999998)
5-{[(2-Amino-9H-purin-6-YL)oxy]methyl}-2-pyrrolidinone
C10H12N6O2 (248.10216920000002)
3-[4-Hydroxy-3-(4-hydroxy-3-methylbut-2-enyl)phenyl]prop-2-enoic acid
3-(4-Oxopentyl)-8-hydroxy-3,4-dihydro-1H-2-benzopyran-1-one
2(1H)-pyrimidinone, tetrahydro-4-hydroxy-1-beta-D-ribofuranosyl-
C9H16N2O6 (248.10083160000002)
D009676 - Noxae > D000963 - Antimetabolites
2H-Pyran-2-one, 5,6-dihydro-5-hydroxy-4-methoxy-6-(2-phenylethyl)-, (5R-cis)-
3,4-Dihydroxy-5-prenylcinnamic acid
A hydroxycinnamic acid that is trans-caffeic acid substituted by a prenyl group at position 5. Isolated from Brazilian propolis, it exhibits antioxidant activity.
5-methyl-N-[(E)-1-thiophen-2-ylethylideneamino]-1H-pyrazole-3-carboxamide
C11H12N4OS (248.07317819999997)
6-methyl-2-[2-[(3-methyl-2-thiophenyl)methylidene]hydrazinyl]-1H-pyrimidin-4-one
C11H12N4OS (248.07317819999997)
(Z)-3-[4-hydroxy-3-[(E)-4-hydroxy-3-methylbut-2-enyl]phenyl]prop-2-enoic acid
1H-Indole-2,3-dione, 1-(trimethylsilyl)-, 3-(O-methyloxime)
4H-Pyrido[1,2-a]pyrimidine-3-acetic acid, 6-hydroxy-4-oxo-, ethyl ester
C12H12N2O4 (248.07970319999998)
2-[(Z)-2,4-Hexadiynylidene]-1,6-dioxaspiro[4.5]decane-3,4-diol
5-Hydroxyindoleacetylglycine
C12H12N2O4 (248.07970319999998)
An N-acylglycine resulting from the formal condensation of the carboxy group of (5-hydroxyindol-3-yl)acetic acid with the amino group of glycine.
7,8-Dihydropyrene-7-carboxylate
A member of the class of pyrenes that is 1,2-dihydropyrene substituted by a carboxy group at position 2.
4-Hydroxyphenobarbital
C12H12N2O4 (248.07970319999998)
Monocyclohexyl phthalate
A phthalic acid monoester resulting from the formal condensation of one of the carboxy groups of phthalic acid with cyclohexanol. It is a metabolite of the commonly used plasticiser dicyclohexyl phthalate.
THR-Glu
C9H16N2O6 (248.10083160000002)
A dipeptide formed from L-threonine and L-glutamic acid residues.
L-gamma-Glu-L-THR
C9H16N2O6 (248.10083160000002)
A dipeptide obtained by formal condensation of the side-chain carboxy group of L-glutamic acid with the amino group of L-threonnine.
3-(furan-3-yl)-7-(hydroxymethyl)-3a-methyl-3,4,5,6-tetrahydro-2-benzofuran-1-one
7a-hydroxy-8-methyl-3-methylidene-3ah,4h,4ah,8h,9h,9ah-azuleno[6,5-b]furan-2,5-dione
2-methyl-5-(6-methyl-5,6-dihydro-4h-pyran-2-carbonyl)benzene-1,3-diol
7-hydroxy-6-methyl-5-[(3-methylbut-2-en-1-yl)oxy]-3h-2-benzofuran-1-one
2-[(1e,3e,5r,6s)-5,6-dihydroxyhepta-1,3-dien-1-yl]-6-hydroxybenzaldehyde
8-(furan-3-yl)-3,7-dimethyl-2,9-dioxatricyclo[5.3.0.0¹,³]decan-10-one
1-[(2s)-6-hydroxy-7-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-5-yl]ethanone
1-(7-hydroxy-5-methoxy-2,2-dimethylchromen-6-yl)ethanone
(2r)-2-({[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}oxy)butanedioic acid
C9H16N2O6 (248.10083160000002)
1-(7-hydroxy-8-methoxy-2,2-dimethylchromen-6-yl)ethanone
4-[(4e)-hex-4-enoyl]-5-hydroxy-3,6-dimethylcyclohexa-3,5-diene-1,2-dione
2-[(1e,3s,4s,5e)-3,4-dihydroxyhepta-1,5-dien-1-yl]-6-hydroxybenzaldehyde
8-ethyl-3-(hydroxymethyl)-2,8-dimethylchromene-4,7-dione
5-methyl-10h-indolo[3,2-b]quinolin-11-one
C16H12N2O (248.09495819999998)
1-(7-hydroxy-5-methoxy-2,2-dimethylchromen-8-yl)ethanone
(3ar,4ar,7as,8r,9ar)-7a-hydroxy-8-methyl-3-methylidene-3ah,4h,4ah,8h,9h,9ah-azuleno[6,5-b]furan-2,5-dione
7-hydroxy-4-isopropyl-3-methoxy-6-methylchromen-2-one
7-hydroxy-3-(2-hydroxypropyl)-5,6-dimethylisochromen-1-one
3-(4-hydroxyphenyl)-4-(2-methylpropyl)oxolane-2,5-dione
7-hydroxy-2-[(1e)-3-hydroxyprop-1-en-1-yl]-6,8-dimethyl-2,3-dihydro-1-benzopyran-4-one
(3s*,4s*,5r*)-(e)-3,4-dihydroxy-2-(hexa-2,4-diynyliden)-1,6-dioxaspiro-(4,5)decane
{"Ingredient_id": "HBIN009643","Ingredient_name": "(3s*,4s*,5r*)-(e)-3,4-dihydroxy-2-(hexa-2,4-diynyliden)-1,6-dioxaspiro-(4,5)decane","Alias": "NA","Ingredient_formula": "C14H16O4","Ingredient_Smile": "CC#CC#CC=C1C(C(C2(O1)CCCCO2)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5902","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-acetyl-5-hydroxy-2-isopropenyl-3-methoxy-2,3-dihydrobenzofuran
{"Ingredient_id": "HBIN012165","Ingredient_name": "6-acetyl-5-hydroxy-2-isopropenyl-3-methoxy-2,3-dihydrobenzofuran","Alias": "NA","Ingredient_formula": "C14H16O4","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "419","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6beta-hydroxyfraxinellone
{"Ingredient_id": "HBIN012275","Ingredient_name": "6beta-hydroxyfraxinellone","Alias": "NA","Ingredient_formula": "C14H16O4","Ingredient_Smile": "CC1=C2C(=O)OC(C2(CCC1O)C)C3=COC=C3","Ingredient_weight": "248.27 g/mol","OB_score": "15.20442498","CAS_id": "NA","SymMap_id": "SMIT07894","TCMID_id": "NA","TCMSP_id": "MOL006245","TCM_ID_id": "NA","PubChem_id": "478833","DrugBank_id": "NA"}
(6r,7r,8r)-8-methoxygoniodiol
{"Ingredient_id": "HBIN012779","Ingredient_name": "(6r,7r,8r)-8-methoxygoniodiol","Alias": "NA","Ingredient_formula": "C14H16O4","Ingredient_Smile": "COC(C1=CC=CC=C1)C(C2CC=CC(=O)O2)O","Ingredient_weight": "248.27 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13936","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "44566796","DrugBank_id": "NA"}
9beta-hydroxyfraxinellone
{"Ingredient_id": "HBIN014071","Ingredient_name": "9beta-hydroxyfraxinellone","Alias": "NA","Ingredient_formula": "C14H16O4","Ingredient_Smile": "CC1=C2C(=O)OC(C2(CCC1O)C)C3=COC=C3","Ingredient_weight": "248.27 g/mol","OB_score": "96.52281962","CAS_id": "NA","SymMap_id": "SMIT07920","TCMID_id": "NA","TCMSP_id": "MOL006274","TCM_ID_id": "NA","PubChem_id": "478833","DrugBank_id": "NA"}
anticancer alkaloid pmv70p691-050
C16H12N2O (248.09495819999998)
{"Ingredient_id": "HBIN016308","Ingredient_name": "anticancer alkaloid pmv70p691-050","Alias": "NA","Ingredient_formula": "C16H12N2O","Ingredient_Smile": "COC1=C2C(=NC3=CC=CC=C31)C4=CC=CC=C4N2","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1380","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-hydroxy-4,4-dimethyl-8-(prop-1-en-1-yl)-5-oxatricyclo[4.4.0.0¹,³]dec-8-ene-7,10-dione
(2e)-3-{4-hydroxy-3-[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]phenyl}prop-2-enoic acid
3-{5-methylidene-2-oxo-6-[(1e,3e)-penta-1,3-dien-1-yl]-6h-pyran-3-yl}propanoic acid
3-hydroxy-7,8-bis(prop-1-en-1-yl)-1-oxaspiro[4.4]non-7-ene-2,6-dione
5-hydroxy-2-isopropyl-7-methoxy-8-methylchromen-4-one
1-(2,4-dihydroxy-3,5-dimethylphenyl)-6-hydroxyhexa-2,4-dien-1-one
(4s,5z)-4-[(1s,2e)-1-hydroxybut-2-en-1-yl]-1,4-dihydro-2,3-benzodioxocin-10-ol
4,6-dihydroxy-3,3,4,7-tetramethylnaphthalene-1,2-dione
(2e,4e)-1-[2-hydroxy-5-(hydroxymethyl)-4-methoxyphenyl]hexa-2,4-dien-1-one
9-hydroxy-8-phenyl-2,7-dioxabicyclo[4.3.1]decan-3-one
1-(2,4,5-trihydroxy-3,6-dimethylphenyl)hexa-2,4-dien-1-one
1-[(2s)-2-(hydroxymethyl)-8-methoxy-2-methylchromen-6-yl]ethanone
1-[(2s,3r)-6-hydroxy-3-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-5-yl]ethanone
1-[5-hydroxy-3-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-6-yl]ethanone
5-methylindolo[3,2-b]quinolin-11-ol
C16H12N2O (248.09495819999998)
(4ar,8ar,9as)-9a-hydroxy-3,8a-dimethyl-4h,4ah,5h,9h-naphtho[2,3-b]furan-2,8-dione
1-[4-hydroxy-6-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-5-yl]ethanone
3-[4-hydroxy-3-(4-hydroxy-3-methylbut-2-en-1-yl)phenyl]prop-2-enoic acid
8-(hydroxymethyl)-8-methyl-2h,3h,4h-pyrano[2,3-f]chromen-3-ol
3-[5-methylidene-2-oxo-6-(penta-1,3-dien-1-yl)-6h-pyran-3-yl]propanoic acid
(5s,6s)-5-hydroxy-6-[(1r,6s,7r,8s)-8-methyl-9-oxabicyclo[4.2.1]nona-2,4-dien-7-yl]-5,6-dihydropyran-2-one
3-[(5e)-5-[(2e,4e)-hexa-2,4-dien-1-ylidene]-2-oxo-6h-pyran-3-yl]propanoic acid
11-methyltricyclo[6.3.0.0¹,⁵]undeca-2,6-diene-3,6-dicarboxylic acid
3-methylbut-3-en-1-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
1-[(2s)-4-hydroxy-6-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-5-yl]ethanone
methyl 7-hydroxy-2,2,5-trimethylchromene-6-carboxylate
1-[6-hydroxy-7-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-5-yl]ethanone
2-methyl-5-[(6s)-6-methyl-5,6-dihydro-4h-pyran-2-carbonyl]benzene-1,3-diol
(3s)-4-(5-acetyl-2-hydroxyphenyl)-3-methoxy-2-methylidenebutanal
(6r)-6-[(1s,2r)-1-hydroxy-2-methoxy-2-phenylethyl]-5,6-dihydropyran-2-one
n-[2-(1h-indol-3-yl)ethyl]-n-methylmethylsulfanylformamide
C13H16N2OS (248.09832859999997)
4-(hex-4-enoyl)-5-hydroxy-3,6-dimethylcyclohexa-3,5-diene-1,2-dione
7-hydroxy-3-(3-hydroxy-3-methylbutyl)chromen-2-one
7-ethyl-8-hydroxy-6-methoxy-2,3-dimethylchromen-4-one
(2e)-2-methyl-3-[(2s,3s,5r,6s)-2,3,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]prop-2-enoic acid
(2e,3s,4s,5r)-2-(hexa-2,4-diyn-1-ylidene)-1,6-dioxaspiro[4.5]decane-3,4-diol
3-[(5z)-5-[(2e,4e)-hexa-2,4-dien-1-ylidene]-2-oxo-6h-pyran-3-yl]propanoic acid
11-methoxy-10h-indolo[3,2-b]quinoline
C16H12N2O (248.09495819999998)
8-ethyl-2-(hydroxymethyl)-3,8-dimethylchromene-4,7-dione
(3r,3ar,6s)-3-(furan-2-yl)-6-hydroxy-3a,7-dimethyl-3,4,5,6-tetrahydro-2-benzofuran-1-one
(2e)-2-methylbut-2-en-1-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
1-(5-hydroxy-7-methoxy-2,2-dimethylchromen-6-yl)ethanone
1-[2-(hydroxymethyl)-8-methoxy-2-methylchromen-6-yl]ethanone
(3r,3ar)-3-(furan-3-yl)-7-(hydroxymethyl)-3a-methyl-3,4,5,6-tetrahydro-2-benzofuran-1-one
11-methoxy-5h-indolo[3,2-b]quinoline
C16H12N2O (248.09495819999998)
(6r)-6-[(1r,2r)-1-hydroxy-2-methoxy-2-phenylethyl]-5,6-dihydropyran-2-one
(3ar,4ar,7ar,8r,9ar)-7a-hydroxy-8-methyl-3-methylidene-3ah,4h,4ah,8h,9h,9ah-azuleno[6,5-b]furan-2,5-dione
8-acetyl-7-hydroxy-5-(hydroxymethyl)-2-methyl-3,4-dihydro-2h-naphthalen-1-one
1-[2-hydroxy-5-(hydroxymethyl)-4-methoxyphenyl]hexa-2,4-dien-1-one
(3ar,4as,7ar,8r,9ar)-4a-hydroxy-8-methyl-3-methylidene-3ah,4h,7ah,8h,9h,9ah-azuleno[6,5-b]furan-2,5-dione
4-[(2e)-1-hydroxybut-2-en-1-yl]-1,4-dihydro-2,3-benzodioxocin-10-ol
(1r,9r)-1,9-dimethyl-8,13-dioxatricyclo[7.3.1.0²,⁷]trideca-2,4,6-triene-5-carboxylic acid
(2e)-2-[(3,4-dihydroxyphenyl)methylidene]-5-methylhex-4-enoic acid
4-(1-hydroxybut-2-en-1-yl)-1,4-dihydro-2,3-benzodioxocin-10-ol
(5r,6s)-5-hydroxy-4-methoxy-6-(2-phenylethyl)-5,6-dihydropyran-2-one
(1s,6r,8r,9s)-9-hydroxy-8-phenyl-2,7-dioxabicyclo[4.3.1]decan-3-one
4-(hexa-2,4-dienoyl)-3,6-dihydroxy-2,6-dimethylcyclohexa-2,4-dien-1-one
methyl 5-hydroxy-2,2,7-trimethylchromene-6-carboxylate
2-hydroxy-1-(7-methoxy-2,2-dimethylchromen-6-yl)ethanone
(2e,4e)-1-(2,4,5-trihydroxy-3,6-dimethylphenyl)hexa-2,4-dien-1-one
(3r,3ar,6s)-3-(furan-3-yl)-6-hydroxy-3a,7-dimethyl-3,4,5,6-tetrahydro-2-benzofuran-1-one
4a-hydroxy-8-methyl-3-methylidene-3ah,4h,7ah,8h,9h,9ah-azuleno[6,5-b]furan-2,5-dione
(1s,3r,7s,8s)-8-(furan-3-yl)-3,7-dimethyl-2,9-dioxatricyclo[5.3.0.0¹,³]decan-10-one
(3s,8s)-8-(hydroxymethyl)-8-methyl-2h,3h,4h-pyrano[2,3-f]chromen-3-ol
2-(hexa-2,4-diyn-1-ylidene)-1,6-dioxaspiro[4.5]decane-3,4-diol
2-methyl-3-[(2s,3s,5r,6s)-2,3,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]prop-2-enoic acid
6-(1-hydroxy-2-methoxy-2-phenylethyl)-5,6-dihydropyran-2-one
(8r)-8-ethyl-2-(hydroxymethyl)-3,8-dimethylchromene-4,7-dione
3-[(6s)-5-methylidene-2-oxo-6-[(1e,3e)-penta-1,3-dien-1-yl]-6h-pyran-3-yl]propanoic acid
(5r,6r,7s,8s)-6,7,8-trihydroxy-5-(hydroxymethyl)-octahydroimidazo[1,2-a]pyridine-2-carboxylic acid
C9H16N2O6 (248.10083160000002)
7-hydroxy-3-[(2r)-2-hydroxypropyl]-5,6-dimethylisochromen-1-one
3-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)phenyl]prop-2-enoic acid
1-[(2r,3s)-6-hydroxy-3-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-5-yl]ethanone
(6s)-4-[(2e,4e)-hexa-2,4-dienoyl]-3,6-dihydroxy-2,6-dimethylcyclohexa-2,4-dien-1-one
3-(furan-3-yl)-6-hydroxy-3a,7-dimethyl-3,4,5,6-tetrahydro-2-benzofuran-1-one
(3r,5r)-3-hydroxy-7,8-bis[(1e)-prop-1-en-1-yl]-1-oxaspiro[4.4]non-7-ene-2,6-dione
3-hydroxy-8-isopropyl-5-oxo-7,8-dihydro-6h-naphthalene-2-carboxylic acid
2-(3,4-dihydroxyhepta-1,5-dien-1-yl)-6-hydroxybenzaldehyde
3-[5-(hexa-2,4-dien-1-ylidene)-2-oxo-6h-pyran-3-yl]propanoic acid
(8s)-8-ethyl-3-(hydroxymethyl)-2,8-dimethylchromene-4,7-dione
(4s)-4-amino-4-{[(1s,2r)-1-carboxy-2-hydroxypropyl]-c-hydroxycarbonimidoyl}butanoic acid
C9H16N2O6 (248.10083160000002)
(2s)-8-acetyl-7-hydroxy-5-(hydroxymethyl)-2-methyl-3,4-dihydro-2h-naphthalen-1-one
(2r)-2-(2-butoxy-2-oxoethyl)-2-hydroxybutanedioic acid
methyl 8-methoxy-2,2-dimethylchromene-6-carboxylate
(8r)-3-hydroxy-8-isopropyl-5-oxo-7,8-dihydro-6h-naphthalene-2-carboxylic acid
(1s,3r,4r,6r,8r,9r,11r,12r)-11-hydroxy-6,9-dimethyl-10-methylidene-5,13-dioxapentacyclo[7.4.0.0¹,¹².0³,⁸.0⁴,⁶]tridecan-7-one
(3r,3ar,6r)-3-(furan-3-yl)-6-hydroxy-3a,7-dimethyl-3,4,5,6-tetrahydro-2-benzofuran-1-one
5-hydroxy-6-{8-methyl-9-oxabicyclo[4.2.1]nona-2,4-dien-7-yl}-5,6-dihydropyran-2-one
1-[(2r,3s)-5-hydroxy-3-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-6-yl]ethanone
1-[6-hydroxy-3-methoxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-5-yl]ethanone
2-{2-[5-(prop-1-yn-1-yl)thiophen-2-yl]ethenyl}oxan-3-ol
4-amino-7-methoxy-2,6-dimethylisoquinoline-3,5,8-trione
C12H12N2O4 (248.07970319999998)